Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 110

1.

Mechanism for improved insulin sensitivity after gastric bypass surgery.

Bikman BT, Zheng D, Pories WJ, Chapman W, Pender JR, Bowden RC, Reed MA, Cortright RN, Tapscott EB, Houmard JA, Tanner CJ, Lee J, Dohm GL.

J Clin Endocrinol Metab. 2008 Dec;93(12):4656-63. doi: 10.1210/jc.2008-1030.

2.

Insulin resistance in nondiabetic morbidly obese patients: effect of bariatric surgery.

Pereira JA, Lazarin MA, Pareja JC, de Souza A, Muscelli E.

Obes Res. 2003 Dec;11(12):1495-501.

3.

The role of beta-cell function and insulin sensitivity in the remission of type 2 diabetes after gastric bypass surgery.

Nannipieri M, Mari A, Anselmino M, Baldi S, Barsotti E, Guarino D, Camastra S, Bellini R, Berta RD, Ferrannini E.

J Clin Endocrinol Metab. 2011 Sep;96(9):E1372-9. doi: 10.1210/jc.2011-0446.

PMID:
21778221
4.

Early and longer term effects of gastric bypass surgery on tissue-specific insulin sensitivity and beta cell function in morbidly obese patients with and without type 2 diabetes.

Camastra S, Gastaldelli A, Mari A, Bonuccelli S, Scartabelli G, Frascerra S, Baldi S, Nannipieri M, Rebelos E, Anselmino M, Muscelli E, Ferrannini E.

Diabetologia. 2011 Aug;54(8):2093-102. doi: 10.1007/s00125-011-2193-6.

PMID:
21614570
5.

Roux-en-Y gastric bypass corrects hyperinsulinemia implications for the remission of type 2 diabetes.

Reed MA, Pories WJ, Chapman W, Pender J, Bowden R, Barakat H, Gavin TP, Green T, Tapscott E, Zheng D, Shankley N, Yieh L, Polidori D, Piccoli SP, Brenner-Gati L, Dohm GL.

J Clin Endocrinol Metab. 2011 Aug;96(8):2525-31. doi: 10.1210/jc.2011-0165.

PMID:
21593117
6.

GRB14, GPD1, and GDF8 as potential network collaborators in weight loss-induced improvements in insulin action in human skeletal muscle.

Park JJ, Berggren JR, Hulver MW, Houmard JA, Hoffman EP.

Physiol Genomics. 2006 Oct 11;27(2):114-21.

7.

Glucose utilization in morbidly obese subjects before and after weight loss by gastric bypass operation.

Burstein R, Epstein Y, Charuzi I, Suessholz A, Karnieli E, Shapiro Y.

Int J Obes Relat Metab Disord. 1995 Aug;19(8):558-61.

PMID:
7489026
8.

Restoration of normal glucose tolerance in severely obese patients after bilio-pancreatic diversion: role of insulin sensitivity and beta cell function.

Mari A, Manco M, Guidone C, Nanni G, Castagneto M, Mingrone G, Ferrannini E.

Diabetologia. 2006 Sep;49(9):2136-43.

PMID:
16819611
9.

Diabetes remission and insulin secretion after gastric bypass in patients with body mass index <35 kg/m2.

Lee WJ, Chong K, Chen CY, Chen SC, Lee YC, Ser KH, Chuang LM.

Obes Surg. 2011 Jul;21(7):889-95. doi: 10.1007/s11695-011-0401-6.

PMID:
21499957
10.

Alterations in gastrointestinal, endocrine, and metabolic processes after bariatric Roux-en-Y gastric bypass surgery.

Anderwald CH, Tura A, Promintzer-Schifferl M, Prager G, Stadler M, Ludvik B, Esterbauer H, Bischof MG, Luger A, Pacini G, Krebs M.

Diabetes Care. 2012 Dec;35(12):2580-7. doi: 10.2337/dc12-0197.

11.

Effect of Bariatric Surgery on Adipose Tissue Glucose Metabolism in Different Depots in Patients With or Without Type 2 Diabetes.

Dadson P, Landini L, Helmiö M, Hannukainen JC, Immonen H, Honka MJ, Bucci M, Savisto N, Soinio M, Salminen P, Parkkola R, Pihlajamäki J, Iozzo P, Ferrannini E, Nuutila P.

Diabetes Care. 2016 Feb;39(2):292-9. doi: 10.2337/dc15-1447.

PMID:
26681717
12.

GLP-1 and adiponectin: effect of weight loss after dietary restriction and gastric bypass in morbidly obese patients with normal and abnormal glucose metabolism.

de Carvalho CP, Marin DM, de Souza AL, Pareja JC, Chaim EA, de Barros Mazon S, da Silva CA, Geloneze B, Muscelli E, Alegre SM.

Obes Surg. 2009 Mar;19(3):313-20. doi: 10.1007/s11695-008-9678-5.

PMID:
18815849
13.

Differential effect of weight loss on insulin resistance in surgically treated obese patients.

Muscelli E, Mingrone G, Camastra S, Manco M, Pereira JA, Pareja JC, Ferrannini E.

Am J Med. 2005 Jan;118(1):51-7.

PMID:
15639210
14.

Beta cell function after weight loss: a clinical trial comparing gastric bypass surgery and intensive lifestyle intervention.

Hofsø D, Jenssen T, Bollerslev J, Ueland T, Godang K, Stumvoll M, Sandbu R, Røislien J, Hjelmesæth J.

Eur J Endocrinol. 2011 Feb;164(2):231-8. doi: 10.1530/EJE-10-0804.

15.

Surgical treatment of type 2 diabetes in subjects with mild obesity: mechanisms underlying metabolic improvements.

Fellici AC, Lambert G, Lima MM, Pareja JC, Rodovalho S, Chaim EA, Geloneze B.

Obes Surg. 2015 Jan;25(1):36-44. doi: 10.1007/s11695-014-1377-9.

PMID:
25098565
16.

Mechanisms of improved glycaemic control after Roux-en-Y gastric bypass.

Bojsen-Møller KN.

Dan Med J. 2015 Apr;62(4):B5057. Review.

PMID:
25872541
17.

Enhanced glucose metabolism in cultured human skeletal muscle after Roux-en-Y gastric bypass surgery.

Nascimento EB, Riedl I, Jiang LQ, Kulkarni SS, Näslund E, Krook A.

Surg Obes Relat Dis. 2015 May-Jun;11(3):592-601. doi: 10.1016/j.soard.2014.11.001.

PMID:
25862179
18.

Restoration of insulin responsiveness in skeletal muscle of morbidly obese patients after weight loss. Effect on muscle glucose transport and glucose transporter GLUT4.

Friedman JE, Dohm GL, Leggett-Frazier N, Elton CW, Tapscott EB, Pories WP, Caro JF.

J Clin Invest. 1992 Feb;89(2):701-5.

19.

Bariatric surgery in morbidly obese insulin resistant humans normalises insulin signalling but not insulin-stimulated glucose disposal.

Chen MZ, Hudson CA, Vincent EE, de Berker DA, May MT, Hers I, Dayan CM, Andrews RC, Tavaré JM.

PLoS One. 2015 Apr 13;10(4):e0120084. doi: 10.1371/journal.pone.0120084.

20.

Insulin sensitivity and secretion changes after gastric bypass in normotolerant and diabetic obese subjects.

Salinari S, Bertuzzi A, Guidone C, Previti E, Rubino F, Mingrone G.

Ann Surg. 2013 Mar;257(3):462-8. doi: 10.1097/SLA.0b013e318269cf5c.

PMID:
23388352
Items per page

Supplemental Content

Support Center